Provenienza dei contatti di primo grado di Mark Epping-Jordan
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 15 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Mark Epping-Jordan tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
BIOGEN INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
VERNALIS | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
AC IMMUNE SA | Pharmaceuticals: Major | Corporate Officer/Principal | |
GlaxoSmithKline KK
GlaxoSmithKline KK Household/Personal CareConsumer Non-Durables GlaxoSmithKline KK researches, develops, imports, manufactures and sells toiletry products. The company was founded on August 18, 1928 and is headquartered in Tokyo, Japan | Household/Personal Care | Corporate Officer/Principal | |
Synthes, Inc.
Synthes, Inc. Medical SpecialtiesHealth Technology Synthes, Inc. engages in the development, production, and marketing of instruments, implants, as well as biomaterials for surgical fixation, correction, and regeneration of the human skeleton and its soft tissues. The company was founded in 1999 and is headquartered in Solothurn, Switzerland. | Medical Specialties | Director/Board Member | |
MITSUBISHI TANABE PHARMA CORPORATION | Pharmaceuticals: Other | Corporate Officer/Principal | |
FEINTOOL INTERNATIONAL HOLDING AG | Metal Fabrication | Chief Executive Officer | |
École Polytechnique Fédérale de Lausanne | College/University | Graduate Degree | |
Basel - SpA
Basel - SpA MiscellaneousMiscellaneous Part of Smith & Nephew plc, Basel SpA is an Italian company that specializes in medicinal chemicals and botanical products. The company is based in Ravenna, Italy. Basel was acquired by Smith & Nephew plc on April 01, 1995 for $4.80 million. | Miscellaneous | Corporate Officer/Principal | |
Axovan AG
Axovan AG Miscellaneous Commercial ServicesCommercial Services Axovan AG conducts biopharmaceutical research and develops pharmaceuticals. Active in pharmaceutical research and development, it focuses on the family of drug targets called G protein-coupled receptors (GPCRs), which are involved in a number of pathologies. It has developed a validated GPCR-based chemical library through its proprietary chem-informatics platform AXADDIS. Its lead product, clasozentan, is an intravenous endothelin receptor antagonist optimized for treating cerebral diseases. It is partnering non-core indication projects (pain, metabolic diseases, inflammation) at earlier stages. The company was founded in 2000 and is headquartered in Allschwil, Switzerland. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
The University of Southampton | College/University | Undergraduate Degree | |
Yale University | College/University | Undergraduate Degree | |
INSEAD | College/University | Masters Business Admin | |
deVGen NV
deVGen NV BiotechnologyHealth Technology deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium. | Biotechnology | Corporate Officer/Principal | |
PricewaterhouseCoopers International Ltd.
PricewaterhouseCoopers International Ltd. Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers International Ltd. operates as an international association of accounting and consultancy firm. The company was founded on June 24, 1998 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Galderma International SAS
Galderma International SAS Pharmaceuticals: MajorHealth Technology Galderma SA develops and markets therapeutic and aesthetic solutions for dermatology. It provides medical dermatological solutions for acne, rosacea, psoriasis and other steroid-responsive dermatoses, onychomycosis, pigmentary disorders, skin cancer and medical aesthetic and corrective solutions for skin senescence. The company was founded in 1981 and is headquartered in Paris, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Geneva | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
University of Milan | College/University | Doctorate Degree | |
ABIONYX PHARMA | Pharmaceuticals: Major | Chairman | |
University of Paris Jussieu | College/University | Doctorate Degree | |
Polytech Clermont-Ferrand | College/University | Doctorate Degree | |
Merck Serono SA
Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
CRI Worldwide LLC
CRI Worldwide LLC Miscellaneous Commercial ServicesCommercial Services CRI Worldwide LLC engages in the provision of inpatient and outpatient clinical research services. It specializes in inpatient and outpatient clinical trials ranging from phase I to IV focusing on pediatrics, adolescents, adults, and elderly in the areas of acute and chronic pain, attention deficit hyperactivity disorder, Alzheimer’s disease, atypical depression, back pain, bipolar disorder, cancer pain, diabetes, epilepsy, fibromyalgia, general anxiety disorder, hepatitis, major depressive disorder, manic depression, migraines/headaches, mild cognitive impairment. The company was founded by Howard A. Hassman in 2000 and is headquartered in Mt. Laurel, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University of Lyon | College/University | Doctorate Degree | |
DIMERIX LIMITED | Pharmaceuticals: Major | Director/Board Member | |
GlaxoSmithKline AG
GlaxoSmithKline AG Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline AG is a Swiss company. | Pharmaceuticals: Major | Corporate Officer/Principal | |
France Invest
France Invest Financial ConglomeratesFinance France Invest is a French association of investors for growth that supports private equity as a lever for business creators and managers to achieve growth. The private company is based in Paris, France and was founded by Maurice Tchenio. The association is at the heart of the economy and aims to share the value created by supporting companies in their innovation and energy transition efforts. | Financial Conglomerates | Director/Board Member | |
Biogen International GmbH
Biogen International GmbH Pharmaceuticals: MajorHealth Technology Biogen International GmbH produces pharmaceuticals. It develops medicines for psoriasis and multiple sclerosis. Its products include FUMADERM and BG-12. The company was founded in 1983 and is headquartered in Lucerne, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Abionic SA
Abionic SA Medical SpecialtiesHealth Technology Abionic SA develops biomedical diagnostic devices. It specializes in in vitro diagnostic devices for allergies detection. The firm?s products include abioSCOPE and abioKIT. Its services encompass research, development, and commercialization of its products. The company was founded by Nicolas Durand, Iwan M?rki, and Theo Lasser in 2010 and is headquartered in Lausanne, Switzerland. | Medical Specialties | Director/Board Member | |
Qwane Biosciences SA
Qwane Biosciences SA Information Technology ServicesTechnology Services Qwane Biosciences SA is a Swiss company that specializes in providing high precision and high-performance electrophysiology tools for in vitro electrical monitoring of biological samples. Qwane Biosciences is based in Lausanne, CH. The private company's micro electrode array products, which are devices comprising micro-fabricated metal electrodes, are used for in vitro recording and stimulation of electrical activity from neuronal cells & tissue or cardiac tissue. The company is also developing mea-based solutions specifically tailored for applications in drug discovery and safety pharmacology. | Information Technology Services | Director/Board Member | |
OBSEVA SA | Pharmaceuticals: Major | Chief Executive Officer | |
Dimerix Bioscience Pty Ltd.
Dimerix Bioscience Pty Ltd. Medical DistributorsDistribution Services Dimerix Bioscience Pty Ltd. engages in the development and commercialization of drug therapies and drug discovery tools. It deals with clinical research organizations to progress its programs through clinical studies. It focuses on the clinical development of its therapeutic product DMX200 which is targeted to treat patients with chronic kidney disease. The company was founded by James Howard Williams on December 16, 2004 and is headquartered in Melbourne, Australia. | Medical Distributors | Chief Executive Officer | |
Pi-Cardia Ltd.
Pi-Cardia Ltd. Medical SpecialtiesHealth Technology Pi-Cardia Ltd. develops catheter for the treatment of aortic stenosis. Its technology is based on delivering mechanical impact for creating fractures in valve calcifications, without injuring the surrounding soft tissue. The company was founded by Eyal Kolka and Erez Golan in 2009 and is headquartered in Rehovot, Israel. | Medical Specialties | Director/Board Member | |
Minoryx Therapeutics SL
Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Inflamalps SA
Inflamalps SA Pharmaceuticals: MajorHealth Technology Inflamalps SA operates as a biopharmaceutical company. The firm focuses on developing topical treatments for inflammation-mediated diseases in ophthalmology and dermatology. The company was founded by Charles Woler, Vincent Mutel and Philippe Meuwly in August 2012 and is headquartered in Monthey, Switzerlands. | Pharmaceuticals: Major | Chief Executive Officer | |
Tmd Advisory SARL | Founder | ||
Actelion Pharmaceuticals Ltd.
Actelion Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals Ltd. is a Swiss company that develops and distributes molecular weight drugs. The company is based in Allschwil, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
SafeHeal SAS
SafeHeal SAS Medical SpecialtiesHealth Technology SafeHeal SAS develops anastomosis protection devices for improved patient recovery and reduced healthcare costs. The company is headquartered in Paris, France. | Medical Specialties | Director/Board Member | |
INSEEC Business School | College/University | Undergraduate Degree | |
May Health SAS
May Health SAS Miscellaneous Commercial ServicesCommercial Services May Health SAS engages in the development of device for the treatment of polycystic ovary syndrome infertility. The company was founded in September 2017 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Chairman | |
Metys Pharmaceuticals AG
Metys Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Part of Novaremed AG, Metys Pharmaceuticals AG is a pharmaceutical company based in Basel, Switzerland. The Swiss company specializes in developing dimiracetam for the prevention of chemotherapy-induced neuropathic pain. The company was founded by Michael Scherz, who has been the CEO since incorporation. Metys Pharmaceuticals was acquired by Novaremed AG on September 07, 2021. | Pharmaceuticals: Major | Director/Board Member | |
Noema Pharma AG
Noema Pharma AG BiotechnologyHealth Technology Noema Pharma AG is a biotechnology company, which engages in the development of orphan neurological disorder therapies. It focuses on understanding and meeting patient needs using novel therapies. The company was founded by Luigi Costa and George Garibaldi and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member | |
Mnemo Therapeutics SAS
Mnemo Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Mnemo Therapeutics SAS is a French biotechnology company that develops cell therapies to create accessible cures for cancer patients. The company is based in Paris, FR, and has subsidiaries in the United States. The company applies a novel approach to cell therapy using its enfinit platform, a groundbreaking drug discovery engine. Mnemo is committed to addressing the challenges in the field of immuno-oncology, such as a lack of cancer-specific targets, long-term persistence, and sensitivity. The company aims to engineer the future of immunotherapies to transform the lives of people with cancer by discovering novel cancer-specific targets and boosting immune activity to treat solid tumors. The company was founded in 2019 by Alain Maïore and Michel Sadelain. Robert LaCaze has been the CEO of the company since 2022. | Miscellaneous Commercial Services | Director/Board Member | |
Home Biosciences SAS
Home Biosciences SAS BiotechnologyHealth Technology Home Biosciences SAS is a biotech venture builder that partners with academics and scientists to develop life-changing therapies for patients. The company is based in France and has subsidiaries in the country. The French company's operating model allows its teams to focus on scientific and operational excellence to expedite and de-risk the discovery and development paths of its projects, which are housed in dedicated ventures and fully financed by Home Biosciences. Home Biosciences was founded in 2019 by Magali Richard and David S. Schilansky, who has been the CEO since its inception. | Biotechnology | Director/Board Member | |
Moon Surgical SAS
Moon Surgical SAS Medical SpecialtiesHealth Technology Moon Surgical SAS is a French medical technology company that is creating a new category of robotic surgery. The company is based in Paris, France and is operated by renowned serial medical innovators and backed by leading venture capitalists. Its Maestro system enhances existing laparoscopic techniques and tools with new capabilities, benefiting the 93%% of patients who currently do not have access to minimally invasive robotic surgery. The CEO of the company is Anne Osdoit. | Medical Specialties | Director/Board Member | |
MedXCell SA
MedXCell SA BiotechnologyHealth Technology MedXCell SA is a European cell therapy venture builder that focuses on identifying scientific breakthroughs and transforming them into clinical assets. The private company is based in Montreux, Switzerland. The Swiss company has a strong industrial mindset and a multidisciplinary expert team with entrepreneurial, clinical, operational, business development, and funding capabilities. MedXCell scouts for promising ideas within its European academic network of partners, selects the most commercially-viable ideas, and co-develops them with academic institutions until the proof-of-principle stage. The company creates pipeline companies based on those ideas that can be funded independently and monetizes those that can be sold or out-licensed as early-stage assets. MedXCell was founded in 2016 by Laurent Zbinden, who has been the CEO since then. | Biotechnology | Director/Board Member |
Statistiche
Distribuzione geografica
Svizzera | 21 |
Francia | 14 |
Regno Unito | 5 |
Stati Uniti | 4 |
Giappone | 3 |
Settori
Health Technology | 28 |
Consumer Services | 10 |
Commercial Services | 7 |
Consumer Non-Durables | 2 |
Producer Manufacturing | 2 |
Posizioni
Director/Board Member | 82 |
Corporate Officer/Principal | 29 |
Chief Executive Officer | 8 |
Chairman | 7 |
Undergraduate Degree | 7 |
Contatti più connessi
- Borsa valori
- Insiders
- Mark Epping-Jordan
- Connessioni Società